TEMPUS AI INC CLASS A (TEM)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for TEM
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| TEM | Director | 53 | ["Member of board of directors since October 2019","Partner on NEA’s healthcare investment team since April 2019","Resident Fellow at American Enterprise Institute since April 2021","23rd Commissioner of the U.S. Food and Drug Administration from May 2017 to April 2019","Venture Partner at NEA from January 2007 to May 2017","Senior advisor to the Administrator of the Centers for Medicare and Medicaid Services in 2004","Contributor to CNBC and CBS News program Face the Nation","Executive committee member of Mount Sinai Health System’s board of directors","Co-chair of board’s education committee","Board member of Wesleyan University","Holds a B.A. from Wesleyan University and an M.D. from Mount Sinai School of Medicine","Extensive experience as a medical policy expert and public health advocate"] | ["Nominating and Corporate Governance Committee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ILMN | Independent Chair | 53 | ["Partner at New Enterprise Associates","senior fellow at AEI","Former FDA Commissioner","Director at Pfizer","United Health","Tempus AI","Extensive policy expertise","Experience as FDA Commissioner (2017-2019)","Senior fellow at AEI","Various roles in public and private sectors","Venture Partner at New Enterprise Associates (2007 – 2017)","FDA Deputy Commissioner for Medical and Scientific Affairs (2005 – 2007)","Senior Advisor for Medical Technology to the FDA Commissioner (2003 – 2004)","Columnist for Wall Street Journal","Contributor to CNBC and CBS Face the Nation","Elected Member of the National Academy of Medicine","Director at United Health","Director at Tempus AI"] | ["Nominating/Corporate Governance"] | 2026 |
| UNH | Former Commissioner of the Food and Drug Administration; Director | 53 | ["Extensive clinical, regulatory and health care expertise","23rd Commissioner of the U.S. Food and Drug Administration","Current Senior Fellow at the American Enterprise Institute","Venture capital experience at New Enterprise Associates","Understanding of national health care policy, patient care and complex regulatory environments"] | ["Health and Clinical Practice Policies","Public Responsibility","Health and Clinical Practice Policies Committee","Public Responsibility Committee"] | 2026 |
| PFE | Director; Chair; Committee Member | 51 | ["Government & Public Policy","Medicine & Science","Healthcare & Pharma"] | ["Chair","Regulatory and Compliance","Science and Technology","Regulatory and Compliance Committee","Science and Technology Committee"] | 2024 |
Biography sourced from the proxy statement filing.
Scott Gottlieb, M.D. has served as a member of our board of directors since October 2019. Dr. Gottlieb has also served on the boards of directors of UnitedHealth Group since November 2025, Illumina, Inc. since February 2020 and Pfizer Inc. since June 2019. Dr. Gottlieb has served as a Partner on NEA s healthcare investment team since April 2019, and a Resident Fellow at American Enterprise Institute since April 2021. Prior to that, he served as the 23rd Commissioner of the U.S. Food and Drug Administration from May 2017 to April 2019. Prior to serving as Commissioner, Dr. Gottlieb held several roles in the public and private sectors, including serving as a Venture Partner at NEA from January 2007 to May 2017, and a senior advisor to the Administrator of the Centers for Medicare and Medicaid Services in 2004. He is presently a contributor to CNBC and the CBS News program Face the Nation. He also currently serves on the executive committee of the Mount Sinai Health System s board of directors and co-chairs the board s education committee. In addition, Dr. Gottlieb serves on the board of directors of Wesleyan University. Dr. Gottlieb holds a B.A. from Wesleyan University and an M.D. from Mount Sinai School of Medicine. We believe that Dr. Gottlieb is qualified to serve on our board of directors because of his extensive experience as a medical policy expert and public health advocate.